Organisation
Hematology
Current researchers
1 - 10 of 16 results
- Cindy Aerts (Member)
- Veerle Beckers (Member)
- Charlotte Caron (Member)
- Ludwine Antoinette Claeys (Member)
- Ann De Becker (Member)
- Nathan De Beule (Member)
- Wouter De Brouwer (Member)
- Inke De Haes (Member)
- Sylvia Faict (Member)
- Karel Fostier (Member)
Projects
1 - 1 of 1
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
1 - 10 of 60
- Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Authors: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pages: 45Number of pages: 17 - Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals(2022)
Authors: Jana Vanden Broeck, Katrien Beeckman, Evelyne Van Gastel, Luc De Keersmaecker, Timothy Devos, Christiane Gérard, Lucien Noens, Dominique Putzeys, Karin Van Poucke, Margareta Haelterman, et al.
Pages: 259-267Number of pages: 9 - The road to personalized myeloma medicine(2022)
Authors: Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, et al.
Pages: 159-169Number of pages: 11 - Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)(2022)
Authors: Xavier Poiré, Carlos Graux, Aurélie Ory, Julie Herman, Frédéric Baron, Hélène Schoemans, Philippe Lewalle, Ann De Becker, Dries Deeren, Zwi Berneman, et al.
Pages: 116-118Number of pages: 3 - Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.(2021)
Authors: Anke Delie, Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure, Frédéric Baron, Dimitri Breems, Ann De Becker, Carlos Graux, Philippe Lewalle, et al.
Pages: 500-508Number of pages: 9 - Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical Research(2021)
Authors: Sylvia Faict, Gaelle Bécel, Adrien Picod, Raïda Bouzid, Agnès Veyradier, Paul Coppo
Pages: 283-293Number of pages: 11 - Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry(2021)
Authors: Timothy Devos, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Alain Gadisseur, Gaëtan Vanstraelen, Hélène Vellemans, Benjamin Bailly, Nikki Granacher, et al.
Pages: 1723-1732Number of pages: 10 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, Marleen Bakkus
Pages: 599-611Number of pages: 13 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Authors: Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pages: 1-16Number of pages: 16 - Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?(2020)
Authors: Sylvia Faict, Tamim Alsuliman, Florent Malard, Alexis Genthon, Eolia Brissot, Zoé Van de Wyngaert, Souhila Ikhlef, Anne Banet, Simona Lapusan, Simona Sestili, et al.